Biological Activities of Naturally Occurring Antibodies Reactive with Candida albicans Mannan

Infection and Immunity

Volumn 72, Issue 1, 2004, Pages 209-218

  Kozel, Thomas R ^a   MacGill, Randall S ^a,b   Percival, Ann ^a   Zhou, Qing ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b GenVec   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; MANNAN; OPSONIN;

ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; BINDING KINETICS; CANDIDA ALBICANS; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; SEROTYPE; YEAST CELL;

ADULT; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; CANDIDA ALBICANS; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; HUMANS; MANNANS; NEUTROPHILS; OPSONIN PROTEINS; PHAGOCYTOSIS;

EID: 0346881413     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.1.209-218.2004     Document Type: Article

References (32)

1. Clark, R. A., and W. M. Nauseef. 1996. Isolation and functional analysis of neutrophils, p. 7.23.1-7.23.3. In J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology. John Wiley & Sons, Inc., New York, N.Y.
2. Faux, J. A., A. E. Agbarakwe, S. A. Misbah, and H. M. Chapel. 1992. A comparison of specific IgG antibody levels to the cell wall mannan of Candida albicans in normal individuals and in patients with primary antibody deficiency. J. Immunol. Methods 153:167-172.
3. Ferrante, A., and Y. H. Thong. 1979. Requirement of heat-labile opsonins for maximal phgagocytosis of Candida albicans. Sabouraudia 17:293-297.
4. Fine, D. P., S. R. Marney, Jr., D. G. Colley, J. S. Sergent, and R. M. Des Prez. 1972. C3 shunt activation in human serum chelated with EGTA. J. Immunol. 109:807-809.
5. Fukazawa, Y., K. Kagaya, M. Suzuki, and T. Shinoda. 1997. Serological specificity and biological activity of cell wall polysaccharides of medically important yeasts, p. 17-24. In S. Suzuki and M. Suzuki (ed.), Fungal cells in biodefense mechanism. Saikon Publishing, Tokyo, Japan.
6. Greenfield, R. A., J. L. Stephens, M. J. Bussey, and J. M. Jones. 1983. Quantitation of antibody to Candida mannan by enzyme-linked immunosorbent assay. J. Lab. Clin. Med. 101:758-771.
7. Han, Y., and J. E. Cutler. 1995. Antibody response that protects against disseminated candidiasis. Infect. Immun. 63:2714-2719.
8. Han, Y., T. R. Kozel, M. X. Zhang, R. S. MacGill, R. J. Carroll, and J. E. Cutler. 2001. Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis. J. Immunol. 167:1550-1557.
9. Han, Y., M. H. Riesselman, and J. E. Cutler. 2000. Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect. Immun. 68:1649-1654.
10. Han, Y., M. A. Ulrich, and J. E. Cutler. 1999. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis. J. Infect. Dis. 179:1477-1484.
11. Harlow, E., and D. Lane. 1996. Antibodies: a laboratory manual, p. 283-318. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
12. Hasenclever, H. F., and W. O. Mitchell. 1961. Antigenic studies of Candida. I. Observation of two antigenic groups in Candida albicans. J. Bacteriol. 82:570-573.
13. Haworth, W. N., R. L. Heath, and S. Peat. 1941. The constitution of yeast mannan. J. Chem. Soc. 833-842.
14. Hayette, M. P., G. Strecker, C. Jaille, D. Dive, D. Camus, D. W. R. Mackenzie, and D. Poulain. 1992. Presence of human antibodies reacting with Candida albicans O-linked oligomannosides revealed by using an enzyme-linked immunosorbent assay and neoglycolipids. J. Clin. Microbiol. 30:411-417.
15. Horstmann, R. D., M. K. Pangburn, and H. J. Muller-Eberhard. 1985. Species specificity of recognition by the alternative pathway of complement. J. Immunol. 134:1101-1104.
16. Jones, J. K. N., and R. J. Stoodley. 1965. Fractionation using copper complexes. Methods Carbohydr. Chem. 5:36-38.
17. Jones, J. M. 1980. Quantitation of antibody against cell wall mannan and a major cytoplasmic antigen of Candida in rabbits, mice, and humans. Infect. Immun. 30:78-89.
18. Kobayashi, H., M. Komido, M. Watanabe, K. Matsuda, M. Suzuki, T. Ikeda, H. Oyamada, N. Shibata, and S. Suzuki. 1994. Structure of cell wall mannan of Candida kefyr IFO 0586. Infect. Immun. 62:4425-4431.
19. Kozel, T. R., L. C. Weinhold, and D. M. Lupan. 1996. Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans. Infect. Immun. 64:3360-3368.
20. Kozel, T. R., M. A. Wilson, and W. H. Welch. 1992. Kinetic analysis of the amplification phase for activation and binding of C3 to encapsulated and nonencapsulated Cryptococcus neoformans. Infect. Immun. 60:3122-3127.
21. Lehmann, P. F., and E. Reiss. 1980. Comparison by ELISA of serum anti-Candida albicans mannan IgG levels of a normal population and in diseased patients. Mycopathologia 70:89-93.
22. Meri, T., A. Hartmann, D. Lenk, R. Eck, R. Wurzner, J. Hellwage, S. Meri, and P. F. Zipfel. 2002. The yeast Candida albicans binds complement regulators factor H and FHL-1. Infect. Immun. 70:5185-5192.
23. Morrison, R. P., and J. E. Cutler. 1981. In vitro studies of the interaction of murine phagocytic cells with Candida albicans. J. Reticuloendothel. Soc. 29:23-34.
24. Peat, S., W. J. Whelan, and T. E. Edwards. 1961. Polysaccharides of baker's yeast. IV. Mannan. J. Chem. Soc. 1:29-34.
25. Peterman, J. H. 1991. Immunochemical considerations in the analysis of data from non-competitive solid-phase immunoassays, p. 47-65. In J. E. Butler (ed.), Immunochemistry of solid-phase immunoassay. CRC Press, Inc., Boca Raton, Fla.
26. Platts-Mills, T. A. E., and K. Ishizaka. 1974. Activation of the alternative pathway of human complement by rabbit cells. J. Immunol. 113:348-357.
27. Suzuki, S. 1997. Immunochemical study on mannans of genus Candida. I. Structural investigation of antigenic factors 1, 4, 5, 6, 8, 9, 11, 13, 13b and 34. Curr. Top. Med. Mycol. 8:57-70.
28. Taborda, C. P., and A. Casadevall. 2001. Immunoglobulin M efficacy against Cryptococcus neoformans: mechanism, dose dependence, and prozone-like effects in passive protection experiments. J. Immunol. 166:2100-2107.
29. Taborda, C. P., J. Rivera, O. Zaragoza, and A. Casadevall. 2003. More is not necessarily better: prozone-like effects in passive immunization with IgG. J. Immunol. 170:3621-3630.
30. Tsuchiya, T., Y. Fukazawa, M. Taguchi, T. Nakase, and T. Shinoda. 1974. Serologic aspects on yeast classification. Mycopathol. Mycol. Appl. 53:77-91.
31. Zhang, M. X., and T. R. Kozel. 1998. Mannan-specific immunoglobulin G antibodies in normal human serum accelerate binding of C3 to Candida albicans via the alternative complement pathway. Infect. Immun. 66:4845-4850.
32. Zhang, M. X., D. M. Lupan, and T. R. Kozel. 1997. Mannan-specific IgG antibodies in normal human serum mediate classical pathway initiation of C3 binding to Candida albicans. Infect. Immun. 65:3822-3827.